Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06562543
What this trial is testing

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 78
Testing effectiveness (Phase 2)Study completedNCT03953235
What this trial is testing

A Personalized Cancer Vaccine Targeting Shared Neoantigens

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerPancreatic Cancer+2 more
Gritstone bio, Inc. 39
Not applicableEnded earlyNCT02560740
What this trial is testing

The Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy

Who this might be right for
Colorectal CancerAdvanced Gastric CancerNeuropathy
SMR Biotech Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT01956149
What this trial is testing

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 65
Not applicableNot Yet RecruitingNCT04658589
What this trial is testing

Laparoscopic vs. Open Distal Gastrectomy After Neoadjuvant Chemotherapy

Who this might be right for
Stomach Neoplasm
Chonnam National University Hospital 238
Testing effectiveness (Phase 2)Study completedNCT02527785
What this trial is testing

Study of Oxaliplatin, Irinotecan, and S-1 in Gastric Cancer

Who this might be right for
Stomach Neoplasm
Hallym University Medical Center 44
Testing effectiveness (Phase 2)Ended earlyNCT00470535
What this trial is testing

Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT02178358
What this trial is testing

LY2157299 in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eli Lilly and Company 132
Not applicableStudy completedNCT02132858
What this trial is testing

Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

Who this might be right for
Mucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the Rectum+6 more
Fox Chase Cancer Center 43
Testing effectiveness (Phase 2)Looking for participantsNCT07780838
What this trial is testing

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma

Who this might be right for
Locally Advanced Ampulla of Vater CarcinomaLocally Advanced Biliary Tract CarcinomaLocally Advanced Extrahepatic Cholangiocarcinoma+20 more
Ohio State University Comprehensive Cancer Center 29
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Not applicableLooking for participantsNCT05740995
What this trial is testing

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Shanghai Zhongshan Hospital 40
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Early research (Phase 1)Study completedNCT00077519
What this trial is testing

Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)UnknownNCT04503967
What this trial is testing

Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05990231
What this trial is testing

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Testing effectiveness (Phase 2)Ended earlyNCT04479436
What this trial is testing

Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Daiichi Sankyo 40
Not applicableAvailableNCT04091295
What this trial is testing

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Who this might be right for
Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more
Aveni Foundation
Testing effectiveness (Phase 2)Study completedNCT00094965
What this trial is testing

Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function

Who this might be right for
Gastrointestinal Cancer
Sanofi 43
Testing effectiveness (Phase 2)Study completedNCT05039177
What this trial is testing

ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma
Erasca, Inc. 101
Next Page